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Given the continued successes of the world’s lymphatic filariasis (LF) elimination programs
and the growing successes of many malaria elimination efforts, the necessity of low cost
tools and methodologies applicable to long-term disease surveillance is greater than ever
before. As many countries reach the end of their LF mass drug administration programs and
a growing number of countries realize unprecedented successes in their malaria interven-
tion efforts, the need for practical molecular xenomonitoring (MX), capable of providing
surveillance for disease recrudescence in settings of decreased parasite prevalence is
increasingly clear. Current protocols, however, require testing of mosquitoes in pools of 25
or fewer, making high-throughput examination a challenge. The new method we present
here screens the excreta/feces from hundreds of mosquitoes per pool and provides proof-
of-concept for a practical alternative to traditional methodologies resulting in significant cost
and labor savings.
Methodology/Principal Findings
Excreta/feces of laboratory reared Aedes aegypti or Anopheles stephensimosquitoes pro-
vided with a Brugia malayimicrofilaria-positive or Plasmodium vivax-positive blood meal
respectively were tested for the presence of parasite DNA using real-time PCR. A titration of
samples containing various volumes of B.malayi-negative mosquito feces mixed with posi-
tive excreta/feces was also tested to determine sensitivity of detection. Real-time PCR
amplification of B.malayi and P. vivax DNA from the excreta/feces of infected mosquitoes
was demonstrated, and B.malayi DNA in excreta/feces from one to two mf-positive blood
meal-receiving mosquitoes was detected when pooled with volumes of feces from as many
as 500 uninfected mosquitoes.
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Conclusions/Significance
While the operationalizing of excreta/feces testing may require the development of new
strategies for sample collection, the high-throughput nature of this new methodology has
the potential to greatly reduce MX costs. This will prove particularly useful in post-transmis-
sion-interruption settings, where this inexpensive approach to long-term surveillance will
help to stretch the budgets of LF and malaria elimination programs. Furthermore, as this
methodology is adaptable to the detection of both single celled (P. vivax) and multicellular
eukaryotic pathogens (B.malayi), exploration of its use for the detection of various other
mosquito-borne diseases including viruses should be considered. Additionally, integration
strategies utilizing excreta/feces testing for the simultaneous surveillance of multiple dis-
eases should be explored.
Author Summary
As a non-invasive method of indirectly monitoring insect-borne disease, molecular xenomo-
nitoring (MX), the molecular testing of insects for the presence of a pathogen, can provide
important information about disease prevalence without the need for human sampling.
However, given the successes of tropical disease elimination programs, including many lym-
phatic filariasis and malaria elimination efforts, parasite levels in many locations are declin-
ing. This decrease in prevalence requires the sampling of increased numbers of vectors for
disease surveillance and recrudescence monitoring. Such increased sampling poses a chal-
lenge since it results in additional costs and labor. In light of these difficulties, high-through-
put methodologies for MX are necessary to provide elimination programs with cost-
reducing alternatives to long-term disease surveillance. Here we demonstrate proof-of-con-
cept for a new method that samples large numbers of mosquitoes using PCR to screen
excreta/feces for filarial or malarial parasites. If operationalized, this approach to MX will
provide a practical “first-alert” system that will enable cost-minimizing surveillance in post-
transmission-interruption settings. Given this potential, the applicability of this approach to
the monitoring of various mosquito-borne diseases should be explored further, as this plat-
form will prove useful for surveillance efforts for a wide variety of pathogens.
Introduction
Spanning 73 countries and territories and placing an estimated 1.39 billion individuals at risk
of infection, lymphatic filariasis (LF) presents a considerable risk to global health [1]. Similarly,
with an estimated 198 million malaria infections and 584,000 malaria-related deaths in 2013,
the global burden of human malaria is staggering [2]. Yet despite the wide ranging impacts of
these diseases, global elimination efforts have made significant strides, spearheaded by mass
drug administration (MDA) programs supported by large pharmaceutical donors [3–5] and
the widespread use of insecticidal bed nets [6–9]. As a result, disease prevalence in many loca-
tions has decreased dramatically, enabling a growing number of countries to discontinue their
treatment efforts for LF [5, 10] and spurring the creation of an increasing number of malaria
elimination programs [11–13]. However, lessons learned as a result of LF elimination efforts
have shown that the cessation of MDA, recommended after the successful passing of a trans-
mission assessment survey [14], results in an additional set of programmatic challenges.
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Foremost in such post-intervention settings is the issue of post-MDA surveillance, as vigilant
monitoring is required to ensure that recrudescence of disease has not occurred [15]. This
monitoring is costly and current efforts for LF are centered upon the periodic sampling of the
human population in order to examine circulating levels of filarial antigen [16–17]. While
effective, these efforts require blood sampling of the human population. The invasive nature of
this practice, coupled with the requirement of informed consent, results in participation chal-
lenges [14] that logically increase as populations become further removed from the time of
widespread disease transmission. While still largely of future concern, similar challenges likely
await the malaria community as control efforts continue to reduce the burden of disease, mak-
ing this programmatic obstacle one of utmost global importance.
Molecular xenomonitoring (MX), the testing of vectors for the presence of parasite genetic
material, has been proposed as a non-invasive means of conducting post-MDA surveillance
for LF [14, 17–18]. Although precise correlations between levels of parasite within the vector
population and levels within the human population have not been conclusively established, par-
asite presence within the vector population is indicative of the potential for disease transmission.
Furthermore, when monitoring for LF in locations endemic for theWuchereria bancrofti para-
site, a pathogen without a known zoonotic host [19], presence is directly indicative of active
human infection. Yet despite its many advantages, MX is costly and when used for monitoring
in a post-MDA setting, typically requires the collection and sampling of many thousands of
mosquitoes [18, 20–21]. Therefore, as a growing number of countries continue to enter the sur-
veillance phases of their LF eradication programs, alternative methodologies for streamlining,
simplifying, and reducing the costs associated with post-MDAmonitoring will be required.
As an alternative to traditional approaches to MX, excreta and feces produced by mosqui-
toes potentially harboring parasites can be tested for the presence of pathogen DNA. Previous
work has demonstrated that vector feces-monitoring for the PCR-based detection of Trypano-
soma cruzi can be used as a means of surveying insect host infection status [22]. Similarly, it
has been shown that genetic material from the Brugia malayi parasite can be successfully
detected in the excreta and feces collected from individual mosquitoes [23]. Building upon
these findings, we describe methodological proof-of-principle for the real-time PCR-based
monitoring for B.malayi parasite DNA in pools of mosquito excreta/feces as a platform for the
surveillance of large numbers of insects. While unconventional, excreta/feces monitoring has
the potential to provide significant time, cost, and labor savings over traditional MX methodol-
ogies due to its exceptionally high-throughput nature. Furthermore, as excreta/feces collection
would likely prove readily adaptable to a variety of both passive and active trapping practices
and platforms, its potential feasibility as an exceedingly low cost, long-term surveillance tool is
great. Equally promising, initial experiments have demonstrated that this approach to MX can
be applied to the detection of Plasmodium vivax DNA, indicating its possible usefulness for the
monitoring of both unicellular and multicellular eukaryotic pathogens. Given these encourag-
ing findings, the further exploration of mosquito excreta/feces testing as a new method for dis-
ease surveillance purposes is warranted and efforts to adapt this alternative MX approach to
other mosquito-borne illnesses should be pursued.
Materials and Methods
Mosquito Rearing for the Accumulation of Excreta/Feces
Accumulation of excreta/feces frommosquitoes potentially infected with B.malayi.
Mosquito cartons containing the excreta/feces from female Aedes aegyptimosquitoes potentially
infected with the B.malayi parasite were received from the Filarial Research Reagent Resource
Center (FR3) located at the University of Georgia, College of Veterinary Medicine, Athens, GA.
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Rearing and infection of mosquitoes occurred in accordance with “SOP Number 8.3” available
on the FR3 website (http://www.filariasiscenter.org/parasites-resources/Protocols/materials-1).
Accumulation of excreta/feces frommosquitoes potentially infected with P. vivax. Mos-
quito cartons containing the excreta/feces from female Anopheles stephensimosquitoes poten-
tially infected with the P. vivax parasite were received from the Centers for Disease Control and
Prevention, Atlanta, GA, USA. Rearing of mosquitoes occurred in accordance with the protocols
described in chapter 2.4 of the “Methods in Anopheles Research”manual [24] available on the
BEI Resources website (https://www.beiresources.org/Catalog/VectorResources.aspx). Infection
of mosquitoes occurred in accordance with previously described methodologies [25].
Accumulation of feces from uninfected mosquitoes. Moist filter paper rafts containing
Culex quinquefasciatus eggs were received from BEI Resources (www.beiresources.org). Eggs
were rinsed into open-topped plastic vessels containing approximately 1 L of tap water at a
depth of approximately 5 cm and a small volume of standard flake-based fish food was added
to the water in each container. Upon maturation into pupae, 50 mosquitoes were transferred
into plastic containers, approximately 5 cm in diameter, containing 1 cm of tap water. These
containers were then placed into waxed cardboard cartons (approximately 18 cm in diameter
by 14.5 cm in height). Cartons were covered with standard mesh tulle and mosquitoes were
allowed to emerge as adults. Upon emergence, a cotton ball soaked in 10% sucrose was placed
on top of each carton and this solution was refreshed daily. Mosquitoes remained within the
cartons producing feces until they expired naturally (10–20 days). At this time, the expired
mosquitoes were removed and the cartons were collected, flattened, and stored at 4°C.
Extraction of DNA from Mosquito Excreta/Feces
Preliminary experiments were designed to determine the effectiveness/efficiency of extracting
DNA from the excreta/feces of mosquitoes potentially infected with the B.malayi parasite. To
make this determination, various extraction protocols and techniques were tested in order to eval-
uate their efficiency (Table 1). Because the FR3-derived mosquito cartons containing excreta/feces
from potentially infected insects were non-waxed, initial samples were either scraped off of the
cartons using a metal spatula, or strips of the carton material (hereafter referred to as carton strips)
were directly used as the starting material for the extraction procedure. The amplification of B.
malayi parasite DNA from all extracts was evaluated using the previously described real-time PCR
primer-probe pairing [26]. Results demonstrated that DNA extractions performed using the
QIAamp DNAMicro Kit (Qiagen, Valencia, CA) provided the most consistent and effective
detection of parasite DNA. For this reason, this kit was used in all subsequent experiments.
To adapt the Qiagen protocol for use with the bulky, brittle mosquito carton material,
minor modifications were made to the manufacturer’s suggested instructions for DNA extrac-
tion from bloodspots. Briefly, carton strips were soaked in 360 μl of Buffer ATL for 1 hour
prior to incubation with Proteinase K at 56°C. Additionally, following incubation at 70°C, sam-
ples were centrifuged at maximum speed for 5 min and supernatants were transferred to new
1.7 ml microcentrifuge tubes. Tubes were centrifuged for an additional 5 min at maximum
speed to pellet residual debris and the supernatants were transferred to QIAamp MinElute col-
umns. Lastly, all samples were incubated in Buffer AE at room temperature for 5 min prior to
the elution of samples from the columns.
Evaluation of Positivity of Excreta/Feces from Mosquitoes Potentially
Infected with B.malayi
Although preliminary experiments demonstrated that excreta/feces derived from vector mos-
quitoes fed on B.malayimicrofilaria (mf)-positive blood resulted in the amplification of
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parasite DNA, the availability of mf-containing blood does not guarantee that all mosquitoes
will feed or ingest parasites while feeding. Additionally, as the FR3’s standard operating proce-
dure (SOP 8.3) requires that mosquitoes spend three to five days as adults prior to the time an
infective blood meal is introduced, a substantial volume of parasite-negative feces was pro-
duced and deposited into mosquito cartons prior to blood feeding. Furthermore, as mosquitoes
are known to excrete while taking a blood meal [27], it is likely that excreta would be deposited
before parasite DNA had reached/been incorporated into the voided material. Therefore, a por-
tion of the voided material collected from mosquitoes provided with mf-positive blood would
likely not contain parasites and would therefore not result in a positive PCR. For this reason, a
large panel of potentially positive excreta/feces samples was tested in order to estimate the rates
of sample positivity. In total, 59 independent samples were tested, with each sample consisting
of a 0.48 cm2 carton strip. Based upon observations of the volume of excreta/feces produced by
single mosquitoes housed in 50 ml conical tubes, it was estimated that the volume of excreta/
feces on each carton strip was equivalent to the average volume produced by one to two mos-
quitoes over a 24 hour period. Negative control extractions were performed on similar volumes
of mosquito feces collected from uninfected C. quinquefasciatus. All samples underwent DNA
extraction using the modified Qiagen procedure described above and were analyzed by 45
cycles of real-time PCR using the published reagent concentrations and cycling protocol [26].
2 μl aliquots of each DNA extract were tested in triplicate and samples returning two or more
positive results were considered positive for B.malayi parasite DNA.
Assay Sensitivity Testing
In order to determine detection limits for the presence of B.malayi-infected excreta/feces in
large pools of uninfected mosquito feces, a titration of samples was created, with each sample
containing a 0.48 cm2 strip from a carton used to house mosquitoes provided with a B.malayi-
positive blood meal mixed with various volumes of uninfected mosquito feces. Feces from
uninfected C. quinquefasciatusmosquitoes were removed from cartons using a cotton swab,
Table 1. Evaluation of extractionmethods for the isolation of DNA frommosquito excreta/feces.
DNA Extraction Method Quantity of Excreta/Feces
(Mosquito Excreta/Feces/Days)*
# of Samples (# of
Positives)
Qiagen DNeasy Blood and Tissue
(Qiagen, Valencia, CA)
62.5 2 (0)
Overnight Soak in 1 x PBS 62.5 8 (0)
Overnight Soak in 1 x TE 62.5 8 (0)
Phire Plant Direct PCR Kit (Thermo Fisher
Scientific, Vantaa, Finland)
62.5 8 (0)
Published Insect Feces Extraction[22] 1–2 5 (0)
Published Insect Feces Extraction[22]
+ Phenol/Chisam Purification
1–2 5 (0)
QIAamp DNA Micro Kit Extraction
(Qiagen, Valencia, CA)
1–2 5 (5)
Nucleospin Blood DNA Kit (Macherey-
Nagel, Bethlehem, PA)
1–2 5 (0)
Nucleospin Blood DNA Kit (Macherey-
Nagel, Bethlehem, PA)
1–2 5 (0)
* Mosquito Excreta/Feces/Days are defined as the estimated quantity of excreta/feces produced by a
single mosquito over a 24 hour period.
doi:10.1371/journal.pntd.0004641.t001
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and the feces-covered cotton was added to each sample. As 50 uninfected mosquitoes were
raised in each carton, and adult mosquitoes were observed to survive for a minimum of 10 days
(with most surviving considerably longer), it was conservatively estimated that each carton
contained a minimum of 500 mosquito feces/days (i.e. the amount of feces produced by 500
mosquitoes in one 24 hour period, or the amount of feces produced by a single mosquito over
a 500 day period). While the distribution of feces within cartons was not precisely uniform, by
sectioning cartons based upon total internal surface area (approximately 1,050 cm2), it was
possible to roughly estimate the number of mosquito feces/days being added to each sample.
Samples estimated to contain approximately 62.5, 125, 250, and 500 feces/days were prepared.
Negative control extractions were also prepared using mosquito feces collected from uninfected
C. quinquefasciatus. All samples were extracted and tested in duplicate reactions using the
same extraction and detection methods as described above for the evaluation of PCR positivity
testing.
Adaptation of Excreta/Feces Testing to the Detection of P. vivax DNA
To test whether the detection of mosquito-borne pathogen DNA from mosquito excreta/feces
was possible for species other than the B.malayi parasite, a set of samples was created using
mosquito excreta/feces produced by carton-raised A. stephensi that had been fed on P. vivax-
positive blood. As was done for B.malayi detection, samples were prepared by excising 0.48
cm2 carton strips containing potentially positive excreta/feces. To establish proof-of-principle,
20 samples were prepared and DNA was extracted using the modified Qiagen protocol
described above. DNA extracts from each sample were tested using a previously described
primer-probe set for the universal detection of Plasmodium species [28] with reaction recipes
and cycling conditions remaining consistent with the authors’ published protocol.
Results
Evaluation of PCR Positivity of Excreta/Feces from Mosquitoes
Potentially Infected with B.malayi
Carton strips were excised from containers used to house A. aegyptimosquitoes provided with
B.malayimf-containing blood and testing was conducted to determine the percentage of
excreta/feces samples containing B.malayi DNA. Such testing was necessary since the produc-
tion of feces can occur prior to the provision of an infective blood meal or before the ingestion
of a blood meal. Furthermore, the availability of infective blood does not guarantee that each
individual mosquito will feed and, dependent upon the mosquito species, localization of para-
site material to voided excreta/feces may take time following blood meal ingestion. Accord-
ingly, DNA was extracted from 59 independent samples, each consisting of a carton strip
measuring 0.48 cm2 and containing excreta/feces from one to two mosquitoes over a 24 hour
period (i.e. one to two mosquito feces/days). Real-time PCR testing, using 2 μl of template
DNA resulted in positive detection for 21 out of 59 samples tested (35.6%). For positive sam-
ples, mean Ct values ranged from 26.62 (+/- 0.24) to 41.98 (+/- 0.03) (Table 2). Because only a
fraction of the deposited mosquito excreta/feces would contain parasite DNA, 35.6% may be a
true indication of the frequency of positive samples.
Assay Sensitivity Testing
A titration of samples containing potentially positive 0.48 cm2 carton strips mixed with varying
amounts of uninfected mosquito feces was prepared in order to estimate the limits of detection
for B. malayi-based excreta/feces testing. In total, five samples containing an estimated 62.5
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mosquito feces/days, six samples containing an estimated 125 mosquito feces/days, six samples
containing an estimated 250 mosquito feces/days, and two samples containing an estimated
500 mosquito feces/days were assayed. As expected, due to the uncertainty of which samples
actually contained B.malayi DNA, a fraction of the samples failed to give positive PCR detec-
tion of B.malayi DNA. However, detection of parasite DNA proved possible at all tested levels
of sensitivity (Table 3).
Adaptation of Excreta/Feces Testing to the Detection of Plasmodium
vivax DNA
To explore whether excreta/feces testing would efficiently detect pathogen DNA from species
other than B.malayi, testing for the presence of the human malaria-causing parasite P. vivax
was performed. To demonstrate proof-of-concept, 20 samples were prepared and tested by
PCR. Each sample was comprised of a 0.48 cm2 carton strip excised from a mosquito container
Table 2. PCR positivity of excreta/feces frommosquitoes potentially infected with B.malayi.
Sample # Ct Value (Std. Dev.) Sample # Ct Value (Std. Dev.)
1 Negative 32 Negative
2 27.75 (+/- 0.15) 33 Negative
3 28.67 (+/- 0.17) 34 Negative
4 Negative 35 Negative
5 38.25 (+/- 2.79) 36 Negative
6 Negative 37 Negative
7 Negative 38 Negative
8 36.53 (+/- 2.33) 39 39.07 (+/- 1.07)
9 40.49 (+/- 0.12) 40 Negative
10 Negative 41 Negative
11 34.80 (+/- 0.70) 42 Negative
12 37.55 (+/- 0.91) 43 Negative
13 41.96 (+/- 2.67) 44 40.74 (+/- 2.17)
14 40.54 (+/- 1.26) 45 Negative
15 Negative 46 31.69 (+/- 0.50)
16 Negative 47 Negative
17 Negative 48 38.88 (+/- 0.49)
18 Negative 49 37.69 (+/- 0.69)
19 Negative 50 Negative
20 Negative 51 40.32 (+/- 0.43)
21 Negative 52 Negative
22 Negative 53 37.49 (+/- 1.53)
23 Negative 54 Negative
24 Negative 55 39.48 (+/- 2.37)
25 41.44 (+/- 0.95) 56 26.62 (+/- 0.24)
26 27.91 (+/- 0.54) 57 Negative
27 Negative 58 Negative
28 41.98 (+/- 0.03) 59 Negative
29 Negative Negative Extract #1 Negative
30 Negative Negative Extract #2 Negative
31 Negative
doi:10.1371/journal.pntd.0004641.t002
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having housed A. stephensi female mosquitoes provided with Plasmodium-positive blood.
Real-time PCR testing of DNA extracted from each sample clearly demonstrated the adaptabil-
ity of excreta/feces testing to the detection of P. vivax since all samples were positive with Ct
values ranging from 26.82 (+/- 0.26) to 29.21 (+/- 0.80) (Table 4).
Table 3. Limits for the detection ofB.malayiDNA in mosquito excreta/feces samples.
Sample ID Quantity of Potentially Positive Excreta/Feces (Mosquito
Excreta/Feces/Days)*




A 1–2 62.5 Negative
B 1–2 62.5 Negative
C 1–2 62.5 Negative
D 1–2 62.5 37.89 (+/- 2.31)
E 1–2 62.5 38.77 (+/- 0.20)
F 1–2 125 30.98 (+/- 0.20)
G 1–2 125 Negative
H 1–2 125 Negative
I 1–2 125 Negative
J 1–2 125 Negative
K 1–2 125 Negative
L 1–2 250 29.56 (+/- 0.01)
M 1–2 250 35.88 (+/- 0.04)
N 1–2 250 Negative
O 1–2 250 38.73 (+/- 0.91)
P 1–2 250 Negative
Q 1–2 250 Negative
R 1–2 500 Negative










* Mosquito Excreta/Feces/Days are defined as the estimated quantity of excreta/feces produced by a single mosquito over a 24 hour period.
doi:10.1371/journal.pntd.0004641.t003
Table 4. PCR positivity of excreta/feces frommosquitoes infected with P. vivax.
Sample # Ct Value (std. dev.) Sample # Ct Value (std. dev.)
1 28.23 (+/- 0.58) 12 28.77 (+/- 0.09)
2 27.84 (+/- 0.05) 13 28.83 (+/- 0.49)
3 27.85 (+/- 0.15) 14 27.88 (+/- 0.19)
4 27.85 (+/- 0.29) 15 27.36 (+/- 0.14)
5 26.82 (+/- 0.26) 16 26.82 (+/- 0.10)
6 27.98 (+/- 0.28) 17 28.00 (+/- 0.27)
7 26.94 (+/- 0.20) 18 28.48 (+/- 0.29)
8 27.26 (+/- 0.32) 19 28.40 (+/- 0.26)
9 27.19 (+/- 0.32) 20 28.07 (+/- 0.12)
10 28.37 (+/- 0.49) Negative Extract #1 Negative
11 29.21 (+/- 0.80) Negative Extract #2 Negative
doi:10.1371/journal.pntd.0004641.t004
Alternative Xenomonitoring for Filarial Parasites and Malaria
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Discussion
While sensitive and less intrusive to the local population than human sampling, the number of
studies implementing current MX practices for the surveillance of LF or malaria has been lim-
ited. Although such efforts provide valuable data [10, 17–18, 21] the routine use of MX for
post-MDA LF surveillance or long-term recrudescence monitoring is not yet standard proce-
dure. Despite the existence of effective molecular tools [28–29], vector monitoring for malaria
is even more uncommon and World Health Organization recommendations for infection
monitoring and prevalence estimation rely solely on human sampling [2]. Limited implemen-
tation has occurred for multiple reasons, including the need to process and test large numbers
of mosquitoes from areas suspected of having low parasite density within the vector population
[10, 18, 21]. Difficulties in establishing a concrete correlation between vector-parasite levels
and human prevalence have further restricted MX implementation [21]. Yet despite these
shortcomings, MX continues to receive attention as the need for post-intervention disease sur-
veillance continues to grow and mosquito trap designs continue to improve [30–34]. Accord-
ingly, methodologies capable of harnessing the advantageous aspects of MX while making its
practice more practical and inexpensive would be of great benefit to global LF and malaria
elimination efforts, as well as to monitoring efforts for other vector-borne diseases.
The work presented here provides methodological proof-of-concept for a novel approach to
MX with the potential to greatly reduce the cost, time, and labor associated with large-scale sur-
veillance efforts. The successful amplification of parasite DNA from pooled mosquito excreta/
feces containing B.malayi genetic material has demonstrated that high-throughput MX for LF
is feasible. In the past, real-time PCR-based MX for the presence of the filariasis-causing para-
sites has been restricted to the testing of pools of 25 or fewer mosquitoes. This is because the
biological mass of mosquitoes and high yields of mosquito DNA associated with pools of large
size results in the inability to detect the presence of small quantities of parasite DNA [35].
However, excreta/feces testing enables the sampling of material obtained from vast numbers of
mosquitoes, while simultaneously limiting the biological mass associated with each sample. As
we have demonstrated, it is possible to detect trace amounts of parasite DNA in pools contain-
ing the voided material from as many as 500 uninfected mosquitoes. Future studies implement-
ing this approach will benefit from the drastic reduction in cost of DNA extractions and PCR
(approximately 20-fold). Furthermore, as it has been shown that non-vector mosquitoes rid
themselves of parasite material more rapidly than vector species (as indicated by a shortened
period of time during which parasite detection is possible within non-vectors [23]), one would
expect to find greater quantities of parasite DNA within the excreta/feces of non-vector mos-
quitoes. Therefore, the testing of mixed pools of vector and non-vector excreta/feces should be
possible. While such testing will result in reduced ability to directly correlate the presence of
parasite with individual vector species, it will likely increase the sensitivity of detection when
surveying for the presence of parasite in post-transmission-interruption settings as both vector
and non-vector mosquitoes potentially harboring parasite material will be screened. In addi-
tion, it is likely that excreta/feces testing will eliminate the need for the labor intensive and time
consuming species-sorting efforts which are commonplace in current MX work [10, 17–18, 21,
36]. By drastically reducing the numbers of pools that must be screened and by eliminating the
need for sorting mosquitoes by species, labor-related time and costs are dramatically reduced.
While operationalizing this alternative approach to MX presents some implementation hur-
dles, adaptation of current passive and active trapping methods to the collection of mosquito
excreta/feces is possible. Such adaptation could occur by transferring live mosquitoes from a
trap to a holding carton, in which they would be sugar fed using a cotton ball, thereby encour-
aging the voiding of waste material. Expired mosquitoes would then be removed and additional
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mosquitoes could be added following further collection from the trap. Periodic testing of the
accumulated excreta/feces would enable the high-throughput screening of the voided material
from a series of such traps. Any trap with the capacity to maintain live mosquitoes could be
used for this purpose including the CDC Gravid Trap, the Ifakara tent trap and others [30, 37].
Alternatively, collection of excreta/feces could occur directly within traps of various designs.
One such design proving readily adaptable to excreta/feces collection in preliminary experi-
ments is the “Large Passive Box Trap” developed by Ritchie, et al [38]. While work aimed at
evaluating the adaptability of this trap to the collection of various species of mosquitoes is cur-
rently ongoing, and further efforts to optimize this trap for the purpose of excreta/feces collec-
tion will be required, simply lining the internal surfaces of this passive trap with waxed paper
provides an uncomplicated method for collecting the accumulated material voided by trapped
mosquitoes (S1 Fig). Swabbing the excreta/feces from the waxed paper then enables the PCR
analysis of pooled material.
Additional testing will be required to determine the stability of parasite DNA in mosquito
excreta/feces over time and under field conditions. However, in the proof-of-concept experi-
ments described in this paper, mosquito excreta/feces containing parasite DNA was allowed
to accumulate for 14–16 days prior to transfer to cold storage. In this setting, parasite DNA
remained stable and detectable (Table 3). While further validation under conditions mimicking
tropical temperatures and humidity will be required, these results are encouraging, as DNA sta-
bility within tropical and sub-tropical climates could present another hurdle when operationa-
lizing this method in the field.
Since production of feces can occur prior to the provision of a parasite-positive blood meal
and since this provision does not ensure that all mosquitoes will ingest and/or metabolize a
parasite, a percentage of the excreta/feces samples collected will likely test negative for parasite
DNA. It is therefore difficult using blood-fed mosquitoes to definitively assess the consistency
of detection of parasite DNA in excreta/feces. During initial testing, we demonstrated that 21
out of 59 samples comprised of 0.48 cm2 carton strips derived from containers used to rear
mosquitoes with a B.malayi-positive blood source were positive (Table 2). However, although
sufficient to fulfill our primary aim of providing methodological proof-of-concept, it cannot be
conclusively determined whether the remaining 38 samples were all truly negative for parasite
DNA. While spiking uninfected excreta/feces samples with extracted B.malayi genomic DNA
would provide clear positive and negative samples, this approach is extremely artificial and has
decreased biological relevance since it eliminates any possible effects of mosquito metabolism
on the integrity of parasite DNA. Since the major uses of excreta/feces testing will likely center
on mapping and long-term, low-cost, post-transmission-interruption recrudescence monitor-
ing, marginally reduced consistency of detection has diminished significance as continuous,
sustainable, high-throughput surveillance would enable detection of even low-levels of parasite
prevalence. The high-throughput nature of this testing was clearly demonstrated by the posi-
tive detection of parasite DNA derived from pools containing various volumes of negative
feces up to 500 mosquito feces/days (Table 3). Detection proved possible at all tested sensitivity
levels and with overall sample positivity rates similar to those obtained when testing potentially
positive excreta/feces samples without the addition of negative feces (36.8% vs. 35.6% respec-
tively). Thus, the inclusion of large amounts of negative feces does not appear to alter detection
efficiency. Given these findings, sustainable, high-throughput surveillance efforts using
excreta/feces screening could serve as a “first-alert” platform, with positive detection serving as
a “red flag” for recrudescence in settings of known transmission interruption. In such a sce-
nario, detection would spur the implementation of more traditional surveillance and monitor-
ing studies.
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By successfully detecting P. vivax DNA in pools of excreta/feces produced by Plasmodium-
positive-blood fed A. stephensi, we have provided proof-of-principle for the application of this
platform to the detection of malaria parasites. Furthermore, the increased rates of sample posi-
tivity and decreased Ct values seen when assaying for P. vivax are not entirely surprising and
indicate this system may work even better for malaria than LF. Estimates have suggested that
the ratio of Plasmodiummerozoites to gametocytes within the peripheral blood is as great as
156:1 [39–40]. Given this ratio, the vast number Plasmodiummerozoites ingested during a
blood meal (up to 32 per infected erythrocyte [41]), and knowledge that merozoites obtained
during blood feeding are unable to undergo further development within the mosquito host
(only gametocytes undergo further development [42]), the great majority of ingested parasites
are simply metabolized and/or eliminated by the mosquito. In contrast, while mosquito hosts
possess measures that provide partial protection against filarial infection [43–44], and environ-
mental conditions are thought to impact rates of parasite survival [45], all filarial parasites
taken up as part of a blood meal are of the correct lifecycle stage (mf) to potentially undergo
further development within the vector host. Therefore, due to the varying natures of their life-
cycles, it follows that a greater percentage of filarids ingested during a blood meal are able to
successfully develop within the mosquito host as compared to Plasmodium. Since successful
parasite development would likely mean the absence of parasite DNA in mosquito excreta/
feces, the lower levels of sample positivity and the more modest Ct values observed during B.
malayi testing compared to P. vivax testing seem logical.
With its adaptability to both B.malayi and P. vivax, MX of mosquito excreta/feces for vari-
ous other mosquito-borne pathogens should be explored. Given the successes realized with the
detection of these parasites, it is extremely likely that similar detection will prove possible for
W. bancrofti and other malaria species. However, the applicability of this new platform to
other types of pathogens should also be examined, since improved high-throughput screening
for RNA viruses such as Dengue, Chikungunya, and Zika would be welcomed programmatic
tools. Furthermore, since all species of biting insects draw from the same reservoir of blood
within a target host, the possibility of cross-vector monitoring should also be considered. For
example, excreta/feces samples collected from mosquitoes could be monitored for the presence
of disease-causing agents having unrelated insect hosts (such as Leishmania ssp. or Loa loa).
Adaptability to various pathogens and the possibility of cross-vector monitoring could also
make excreta/feces sampling an attractive strategy for tropical disease integration efforts. In
light of these factors, and the potential time, cost, and labor savings associated with such appli-
cations, we believe that this proof-of-concept study suggests that further evaluation of this new
method is warranted.
Supporting Information
S1 Fig. Mosquito excreta/feces collection in the modified “Large Passive Box Trap”. Voided
material from mosquitoes entering the passive trap collects on wax paper lining the trap sur-




The authors wish to thank Molly Riggs, Chris Evans, Dr. Mike Dzimianski, Dr. Prasit Supa-
korndej, and Dr. Andy Moorehead (Filarial Research Reagent Resource Center, University
of Georgia College of Veterinary Medicine, Athens, GA) for providing B.malayi-positive
Alternative Xenomonitoring for Filarial Parasites and Malaria
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004641 April 20, 2016 11 / 14
mosquito excreta/feces, and Dr. Paul Howell (Centers for Disease Control and Prevention,
Atlanta, GA) for the provision of Plasmodium-positive material. We would also like to extend
our sincere appreciation to Dr. Eric Ottesen and Dr. Patrick Lammie (Task Force for Global
Health, Decatur, GA), as well as Dr. Sandra Laney (Vulcan, Inc., Seattle, WA) for their contin-
ued support, encouragement, and advice.
Author Contributions
Conceived and designed the experiments: NPWIZ DDC SAW. Performed the experiments:
NPWIZ BPA. Analyzed the data: NPWIZ SAW. Contributed reagents/materials/analysis
tools: NP SAW. Wrote the paper: NP. Contributed to the editing of the manuscript: WIZ BPA
SAW.
References
1. Ichimori K, King JD, Engels D, Yajima A, Mikhailov A, Lammie P, et al. Global Programme to Eliminate
Lymphatic Filariasis: The Processes Underlying Programme Success. PLoS Negl Trop Dis. 2014; 8
(12): e3328. doi: 10.1371/journal.pntd.0003328 PMID: 25502758
2. World Health Organization Global Malaria Programme. Global Malaria Report 2014. Geneva: WHO
Press; 2014.
3. Brady M. Seventh meeting of the Global Alliance to Eliminate Lymphatic Filariasis: reaching the vision
by scaling up, scaling down, and reaching out. Parasit Vectors. 2014; 7:46. doi: 10.1186/1756-3305-7-
46 PMID: 24450283
4. Krentel A, Fischer PU, Weil GJ. A Review of Factors that Influence Compliance with Mass Drug Admin-
istration for Elimination of Lymphatic Filariasis. PLoS Negl Trop Dis. 2013; 7(11): e2447. doi: 10.1371/
journal.pntd.0002447 PMID: 24278486
5. Rebollo MP, Bockarie MJ. Shrinking the lymphatic filariasis map: update on diagnostic tools for map-
ping and transmission monitoring. Parasitology. 2014; 141(14): 1912–1917. doi: 10.1017/
S0031182014001231 PMID: 25225828
6. Sexton AR. Best practices for an insecticide-treated bed net distribution programme in sub-Saharan
eastern Africa. Malar J. 2011; 10:157. doi: 10.1186/1475-2875-10-157 PMID: 21651815
7. Mathanga DP, Mwandama DA, Bauleni A, Chisaka J, Shah MP, Landman KZ, et al. The effectiveness
of long-lasting, insecticide-treated nets in a setting of pyrethroid resistance: a case-control study
among febrile children 6 to 59 months of age in Machinga District, Malawi. Malar J. 2015; 14(1): 457.
doi: 10.1186/s12936-015-0961-3 PMID: 26577571
8. Louis VR, Schoeps A, Tiendrebéogo J, Beiersmann C, Yé M, Damiba MR, et al. An insecticide-treated
bed-net campaign and childhood malaria in Burkina Faso. Bull World Health Organ. 2015; 93(11):
750–758. doi: 10.2471/BLT.14.147702 PMID: 26549902
9. Boudová S, Divala T, Mawindo P, Cohee L, Kalilani-Phiri L, Thesing P, et al. The prevalence of malaria
at first antenatal visit in Blantyre, Malawi declined following a universal bed net campaign. Malar J.
2015; 14(1): 422. doi: 10.1186/s12936-015-0945-3 PMID: 26510414
10. Ramaiah KD, Ottesen EA. Progress and Impact of 13 Years of the Global Programme to Eliminate Lym-
phatic Filariasis on Reducing the Burden of Filarial Disease. PLoS Negl Trop Dis. 2014; 8(11): e3319.
doi: 10.1371/journal.pntd.0003319 PMID: 25412180
11. Gosling J, Case P, Tulloch J, Chandramohan D, Wegbreit J, Newby G, et al. Effective ProgramMan-
agement: A Cornerstone of Malaria Elimination. Am J Trop Med Hyg. 2015; 93(1): 135–138. doi: 10.
4269/ajtmh.14-0255 PMID: 26013372
12. Sun DW, Du JW,Wang GZ, Li YC, He CH, Xue RD, et al. A Cost-Effectiveness Analysis of Plasmodium
falciparumMalaria elimination in Hainan Provence, 2002–2012. Am J Trop Med Hyg. 2015; In press.
13. Kelly GC, Hale E, Donald W, Batarii W, Bugoro H, Nausien J, et al. A high-resolution geospatial surveil-
lance-response system for malaria elimination in Solomon Islands and Vanuatu. Malar J. 2013;
12:108. doi: 10.1186/1475-2875-12-108 PMID: 23514410
14. Chu BK, Deming M, Biritwum N-K, BougmaWR, Dorkenoo AM, El-Setouhy M, et al. Transmission
Assessment Surveys (TAS) to Define Endpoints for Lymphatic Filariasis Mass Drug Administration: A
Multicenter Evaluation. PLoS Negl Trop Dis. 2013; 7(12): e2584. doi: 10.1371/journal.pntd.0002584
PMID: 24340120
15. World Health Organization Global Programme to Eliminate Lymphatic Filariasis. TAS: A Manual for
National Elimination Programmes. Geneva: WHO Press; 2011.
Alternative Xenomonitoring for Filarial Parasites and Malaria
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004641 April 20, 2016 12 / 14
16. Budge PJ, Dorkenoo AM, Sodahlon YK, Fasuyi OB, Mathieu E. Ongoing Surveillance for Lymphatic Fil-
ariasis in Togo: Assessment of Alternatives and Nationwide Reassessment of Transmission Status.
Am J Trop Med Hyg. 2014; 90(1): 89–95. doi: 10.4269/ajtmh.13-0407 PMID: 24189363
17. Rao RU, Nagodavithana KC, Samarasekera SD, Wijegunawardana AD, Premakumara WDY, Perera
SN, et al. A Comprehensive Assessment of Lymphatic Filariasis in Sri Lanka Six Years after Cessation
of Mass Drug Administration. PLoS Negl Trop Dis. 2014; 8(11): e3281. doi: 10.1371/journal.pntd.
0003281 PMID: 25393404
18. Owusu IO, de Souza DK, Anto F, Wilson MD, Boakye DA, Mockarie MJ, et al. Evaluation of human and
mosquito based diagnostic tools for defining endpoints for elimination of Anopheles transmitted lym-
phatic filariasis in Ghana. Trans R Soc Trop Med Hyg. 2015; 109(10): 628–635. doi: 10.1093/trstmh/
trv070 PMID: 26385935
19. Paily KP, Hoti SL, Das PK. A review of the complexity of biology of lymphatic filarial parasites. J Parasit
Dis. 2009; 33(1&2): 3–12.
20. Ramaiah KD, Vanamail P. Surveillance of lymphatic filariasis after stopping ten years of mass drug
administration in rural communities in south India. Trans R Soc Trop Med Hyg. 2013; 107(5): 293–300.
doi: 10.1093/trstmh/trt011 PMID: 23442572
21. Schmaedick MA, Koppel AL, Pilotte N, Torres M, Williams SA, Dobson SL, et al. Molecular Xenomoni-
toring Using Mosquitoes to Map Lymphatic Filariasis after Mass Drug Administration in American
Samoa. PLoS Negl Trop Dis. 2014; 8(8): e3087. doi: 10.1371/journal.pntd.0003087 PMID: 25122037
22. Russomando G, Rojas de Arias A, Almiron M, Figueredo A, Ferreria ME, Morita K. Trypanosoma cruzi:
polymerase chain reaction-based detection in dried feces of Triatoma infestans. Exp Parasitol. 1996;
83(1): 62–66. PMID: 8654552
23. Erickson SM, Fischer K, Weil GJ, Christensen BM, Fischer PU. Distribution of Brugia malayi larvae and
DNA in vector and non-vector mosquitoes: implications for molecular diagnostics. Parasit Vectors.
2009; 2(1): 56. doi: 10.1186/1756-3305-2-56 PMID: 19922607
24. Benedict MQ, Wilkins L, Howell P. Anopheles laboratory biology and culture. In: Benedict MQ, Wilkins
L, Howell P, editors. Methods in AnophelesResearch. Manassas: MR4; 2014. pp. 68–103.
25. Galinski MR, Barnwell J. Nonhuman primate models for human malaria research. In: Abee CR, Mans-
field K, Tardif S, Morris T, editors. Nonhuman Primates in Biomedical Research: Diseases. Oxford:
Academic Press Elsevier; 2012. pp. 299–323.
26. Rao RU, Weil GJ, Fischer K, Supali T, Fischer P. Detection of Brugia Parasite DNA in Human Blood by
Real-Time PCR. J Clin Microbiol. 2006; 44(11): 3887–3893. PMID: 16957038
27. Lahondère C, Lazzari CR. Mosquitoes Cool Down during Blood Feeding to Avoid Overheating. Curr
Biol. 2012; 22(1): 40–45. doi: 10.1016/j.cub.2011.11.029 PMID: 22177900
28. Rougemont M, Van Saanen M, Sahli R, Hinrikson HP, Bille J, Jaton K. Detection of four Plasmodium
species in blood from humans by 18S rRNA gene subunit-based and species-specific real-time PCR
assays. J Clin Microbiol. 2004; 42(12): 5636–5643. PMID: 15583293
29. Sandeu MM, Moussiliou A, Moiroux N, Padonou GG, Massougbodji A, Corbel V, et al. Optimized Pan-
species and speciation duplex real-time PCR assays for Plasmodium parasites detection in malaria
vectors. PLoS One. 2012; 7(12): e52719. doi: 10.1371/journal.pone.0052719 PMID: 23285168
30. Govella NJ, Chaki PP, Geissbuhler Y, Kannady K, Okumu F, Charlwood JD, et al. A new tent trap for
sampling exophagic and endophagic members of the Anopheles gambiae complex. Malar J. 2009;
8:157. doi: 10.1186/1475-2875-8-157 PMID: 19602253
31. Sikulu M, Govella NJ, Ogoma SB, Mpangile J, Kambi SH, Kannady K, et al. Comparative evaluation of
the Ifakara tent trap-B, the standardized resting boxes and the human landing catch for sampling
malaria vectors and other mosquitoes in urban Dar es Salaam, Tanzania. Malar J. 2009; 8:197. doi:
10.1186/1475-2875-8-197 PMID: 19674477
32. Okumu FO, Madumla EP, John AN, Lwetoijera DW, Sumaye RD. Attracting, trapping and killing dis-
ease-transmitting mosquitoes using odor-bated stations—The Ifakara Odor-Baited Stations. Parasit
Vectors. 2010; 1; 3:12. doi: 10.1186/1756-3305-3-12 PMID: 20193085
33. Eiras AE, Buhagiar TS, Ritchie SA. Development of the gravid Aedes trap for the capture of adult
female container-exploiting mosquitoes (Diptera: Culicidae). J Med Entemol. 2014; 51(1): 200–209.
34. Ritchie SA, Buhagiar TS, Townsend M, Hoffmann A, Van Den Hurk AF, McMahon JL, et al. Field valida-
tion of the gravid Aedes trap (GAT) for collection of Aedes aegypti (Diptera: Culicidae). J Med Entemol.
2014; 51(1): 210–219.
35. Rao RU, Atkinson LJ, Ramzy RMR, Helmy H, Farid HA, Bockarie MJ, et al. A Real-Time PCR Assay for
Detection ofWuchereria Bancrofti DNA in Blood and Mosquitoes. Am J Trop Med Hyg. 2006; 74(5):
826–832. PMID: 16687688
Alternative Xenomonitoring for Filarial Parasites and Malaria
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004641 April 20, 2016 13 / 14
36. Boakye DA, Baidoo HA, Glah E, Brown C, Appawu M, Wilson MD. Monitoring lymphatic filariasis inter-
ventions: Adult mosquito sampling, and improved PCR—based pool screening method forWuchereria
bancrofti infection in Anophelesmosquitoes. Filaria J. 2007; 6:13. PMID: 18047647
37. Reiter P. A revised version of the CDCGravid Mosquito Trap. J AmMosq Control Assoc. 1987; 3(2):
325–327. PMID: 3504918
38. Ritchie SA, Cortis G, Paton C, Townsend M, Shroyer D, Zborowski P, et al. A Simple Non-Powered
Passive Trap for the Collection of Mosquitoes for Arbovirus Surveillance. J Med Entomol. 2013; 50(1):
185–194. PMID: 23427669
39. Talman AM, Domarle O, McKenzie FE, Ariey F, Robert V. Gametocytogenesis: the puberty of Plasmo-
dium falciparum. Malar J. 2004; 3:24. PMID: 15253774
40. Eichner M, Diebner HH, Molineaux L, Collins WE, Jeffery GM, Dietz K. Genesis, sequestration and sur-
vival of Plasmodium falciparum gametocytes: parameter estimates for fitting a model to malariatherapy
data. Trans R Soc Trop Med Hyg. 2001; 95(5): 497–501. PMID: 11706658
41. Lew VL. Malaria: endless fascination with merozoite release. Curr Biol. 2005; 15(18): R760–761.
PMID: 16169475
42. Prudêncio M, Rodriguez A, Mota MM. The silent path to thousands of merozoites: The Plasmodium
liver stage. Nat Rev Microbiol. 2006; 4(11): 849–856. PMID: 17041632
43. Bryan JH, Oothman P, Andrews BJ, McGreevy PB. Proceedings: Effects of pharyngeal armature of
mosquitoes on microfilariae of Brugia pahangi. Trans R Soc Trop Med Hyg. 1974; 68(1): 14.
44. McGreevy PB, Bryan JH, Oothuman P, Kolstrup N. The lethal effects of the cibarial and pharyngeal
armatures of mosquitoes on microfilariae. Trans R Soc Trop Med Hyg. 1978; 72(4): 361–368. PMID:
30190
45. Chandra G. Nature limits filarial transmission. Parasit Vectors. 2008; 1(1): 13. doi: 10.1186/1756-3305-
1-13 PMID: 18500974
Alternative Xenomonitoring for Filarial Parasites and Malaria
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0004641 April 20, 2016 14 / 14
